Logo

Harvard/Partners Center for Genetics and Genomics Will Use Affy Arrays in Atherosclerosis Genotyping Study

Feb 16, 2005

NEW YORK, Feb. 16 (GenomeWeb News) - The Center for Genetics and Genomics of Harvard Medical School and Partners HealthCare will use Affymetrix's GeneChip Human Mapping microarrays in a genotyping study of atherosclerosis, the two institutions said today.

 

HPCGG will obtain the arrays by the end of June under an early access program. In the study, which is funded by the Reynolds Foundation, researchers will genotype more than 1,200 patient samples from the Women's Health Study, an ongoing NIH study of cardiovascular disease in which 38,000 women participate.

 

The Human Mapping array is capable of scanning up to 500,000 SNPs, according to Affymetrix.

Breaking News
The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.